ChinaB2BClub

Foshan Qisheng Trading Co., Ltd.

Written by

in

中文名:佛山市启晟贸易有限公司

  • Shoes
  • Synthetic Leather Footwear
  • Textile, Apparel & Footwear
  • 4-Session Canton Fair Exhibitor
Est
2023
Capital
CNY 800,000
Model
Trading Company
Sessions
4
Location
Foshan, Guangdong, China

Foshan Qisheng Trading Co., Ltd. is a trading company of synthetic leather footwear based in Foshan, Guangdong, China. Established in March 2023, the company has participated in four sessions of the Canton Fair, presenting its footwear lines in the Shoes section during Phase 3. Registered capital is CNY 800,000. As a foreign trade enterprise, it operates through partnerships with downstream factories to fulfill customer orders.

The company specializes in synthetic leather footwear, primarily serving as an OEM supplier for wholesale and trading partners. Products are shipped in full-container loads to the Middle East, where Qisheng has become a key supplier to high-end slipper customers. Its focus on factory collaboration and container-based export logistics supports buyers seeking consistent volume and specification compliance.

Key Highlights

  • Established in March 2023 in Foshan, Guangdong, China
  • Four sessions of Canton Fair participation in the Shoes section
  • Specializes in synthetic leather footwear exports
  • OEM orders shipped in full containers to the Middle East

FAQ

What does Foshan Qisheng Trading Co., Ltd. specialize in?

Foshan Qisheng Trading Co., Ltd. specializes in the export of synthetic leather footwear, working with downstream factories to fulfill OEM orders for wholesale and trading partners.

Which markets does Foshan Qisheng Trading Co., Ltd. serve?

The company primarily exports to the Middle East, shipping products in full-container loads and serving as a supplier to high-end slipper customers in the region.

How many Canton Fair sessions has Foshan Qisheng Trading Co., Ltd. attended?

Foshan Qisheng Trading Co., Ltd. has participated in four sessions of the Canton Fair, exhibiting in the Shoes section during Phase 3.